Eculizumab Is an Effective Treatment for Atypical Hemolytic Uremic Syndrome in Pediatric and Adult Patients with or without Identified Genetic Complement Mutations or Complement Factor H Autoantibodies
Autor: | Cataland, Spero R, Feldkamp, Thorsten *, Bedrosian, Camille L., Kincaid, John *, Minetti, Enrico E. * |
---|---|
Zdroj: | In Blood 6 December 2014 124(21):2789-2789 |
Databáze: | ScienceDirect |
Externí odkaz: |